SCHEMBL7562783

SCHEMBL7562783

O=C(N/N=C\c1ncc[nH]1)c1[nH]c2c(Cl)cccc2c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2 P11137 1/20 0.51
MAPT P10636 8/20 0.48
ALDH1A1 P00352 7/20 0.48
LMNA P02545 7/20 0.48
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
POLB P06746 3/20 0.48
TP53 P04637 1/20 0.48
KDM4E B2RXH2 4/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGD P15428 3/20 0.42
PAX8 Q06710 2/20 0.42
TUBB4A P04350 2/20 0.42
TUBB P07437 2/20 0.42
TUBA3C P0DPH7 2/20 0.42
TUBA1B P68363 2/20 0.42
TUBA4A P68366 2/20 0.42
TUBB4B P68371 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533006 1.00 MAP2 (0.51) MAP2MAPTALDH1A1LMNAMEN1
SCHEMBL7531032 0.89 GUSB (0.44) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7678009 0.89 GUSB (0.44) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7557566 0.85 MAPT (0.55) MAP2MAPTALDH1A1LMNAMEN1
SCHEMBL7557568 0.85 MAPT (0.55) MAP2MAPTALDH1A1LMNAMEN1
SCHEMBL7560061 0.82 MAP2 (0.50) MAP2MAPTALDH1A1LMNAMEN1
SCHEMBL7560052 0.82 MAP2 (0.50) MAP2MAPTALDH1A1LMNAMEN1
SCHEMBL7560373 0.81 TUBB4A (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7560370 0.81 TUBB4A (0.49) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL7532782 0.81 MAP2 (0.59) MAP2MAPTALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAP2 1547/4885MAPT 4828/4885ALDH1A1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.